Información del producto
- Bsf 208075,(+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid
- 2-(4,6-Dimethylpyrimidin-2-Yl)Oxy-3-Methoxy-3,3-Di(Phenyl)Propanoic Acid
- (As)-A-[(4,6-Dimethyl-2-Pyrimidinyl)Oxy]--Methoxy--Phenylbenzenepropanoic Acid
- Bsf 208075
- Lu 208075
- (2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid
Ambrisentan is a drug that blocks the endothelin-A receptor and has been shown to decrease natriuretic peptide levels. It also inhibits the binding of endothelin-A and endothelin-B to their receptors on vascular smooth muscle cells, leading to vasodilation. Ambrisentan has been shown to have synergistic effects in combination with other drugs, including multivariate logistic regression analysis of pharmacological agents and a combination therapy group. This drug has shown long term efficacy in treating hypertension, pulmonary edema, and chronic heart failure, among others.
Propiedades químicas
Consulta técnica sobre: 3D-NDB51699 (+/-)-Ambrisentan
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
